Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases

被引：97

作者：

Bardotti, Angela ^{[1
]}

Averani, Giovanni ^{[1
]}

Berti, Francesco ^{[1
]}

Berti, Stefania ^{[1
]}

Carinci, Valeria ^{[1
]}

D'Ascenzi, Sandro ^{[1
]}

Fabbri, Barbara ^{[1
]}

Glannini, Sara ^{[1
]}

Giannozzi, Aldo ^{[1
]}

Magagnoli, Claudia ^{[1
]}

Proietti, Daniela ^{[1
]}

Norelli, Francesco ^{[1
]}

Rappuoli, Rino ^{[1
]}

Ricci, Stefano ^{[1
]}

Costantino, Paolo ^{[1
]}

机构：

[1] Novartis Vaccines & Diagnost Srl, I-53100 Siena, Italy

来源：

VACCINE | 2008年 / 26卷 / 18期

关键词：

glycoconjugate vaccines; physicochemical characterisation; Neisseria meningitidis;

D O I：

10.1016/j.vaccine.2008.01.022

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Bacterial capsular polysaccharides covalently linked to an appropriate carrier protein represent the best tool. to induce a protective immune response against a wide range of bacterial diseases, such as meningococcal infections. We describe here the physico-chemical characterisation of glycoconjugate molecules designed to prepare a vaccine against Neisseria meningitidis serogroups A, C, W135 and Y. The use of a selective conjugation chemistry resulted in well. characterised, reproducible and traceable glycoconjugate that can be consistently manufactured at large scale. A pool of physical and spectroscopic methods was used to establish glycosylation ratio, identity, molecular weight profiles, integrity of carrier protein and sites of glycosylation, assuring effective and consistent lots of vaccines. (C) 2008 Published by Elsevier Ltd.

引用

页码：2284 / 2296

页数：13

共 50 条

[1] Meningococcal glycoconjugate vaccines
Gasparini, Roberto
Panatto, Donatella
[J]. HUMAN VACCINES, 2011, 7 (02): : 170 - 182
[2] Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases
E. A. Khatuntseva
N. E. Nifantiev
[J]. Russian Journal of Bioorganic Chemistry, 2021, 47 : 26 - 52
[3] Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases
Khatuntseva, E. A.
Nifantiev, N. E.
[J]. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (01) : 26 - 52
[4] Vaccines against meningococcal diseases
Knuf, M.
Vogel, U.
[J]. MONATSSCHRIFT KINDERHEILKUNDE, 2013, 161 (12) : 1146 - +
[5] Vaccines against Meningococcal Diseases
Pizza, Mariagrazia
Bekkat-Berkani, Rafik
Rappuoli, Rino
[J]. MICROORGANISMS, 2020, 8 (10) : 1 - 21
[6] VACCINES FOR PREVENTION OF MENINGOCOCCAL DISEASE
FRASCH, CE
[J]. CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 : S134 - S138
[7] Vaccines for prevention of meningococcal disease
Pollard, AJ
Levin, M
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (04) : 333 - 345
[8] Extended helical polysaccharide epitopes and their role in glycoconjugate vaccines against meningococcal meningitis
Jennings, HJ
Pon, R
Lussier, M
Yang, QL
[J]. GLYCOBIOLOGY, 1996, 6 (07) : L2 - L2
[9] Glycoconjugate Vaccines
Fleischhackerova, Anna
Farkas, Pavol
Bystricky, Slavomir
[J]. CHEMICKE LISTY, 2014, 108 (02): : 120 - 126
[10] Glycoconjugate vaccines
Pace, David
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (01) : 11 - 33

← 1 2 3 4 5 →